Your browser doesn't support javascript.
loading
Upregulation of Robo4 expression by SMAD signaling suppresses vascular permeability and mortality in endotoxemia and COVID-19 models.
Morita, Maaya; Yoneda, Aki; Tokunoh, Nagisa; Masaki, Tatsumi; Shirakura, Keisuke; Kinoshita, Mayumi; Hashimoto, Rina; Shigesada, Naoya; Takahashi, Junya; Tachibana, Masashi; Tanaka, Shota; Obana, Masanori; Hino, Nobumasa; Ikawa, Masahito; Tsujikawa, Kazutake; Ono, Chikako; Matsuura, Yoshiharu; Kidoya, Hiroyasu; Takakura, Nobuyuki; Kubota, Yoshiaki; Doi, Takefumi; Takayama, Kazuo; Yoshioka, Yasuo; Fujio, Yasushi; Okada, Yoshiaki.
Afiliación
  • Morita M; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Yoneda A; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Tokunoh N; Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Masaki T; BIKEN Center for Innovative Vaccine Research and Development, The Research Foundation for Microbial Diseases of Osaka University, Osaka 565-0871, Japan.
  • Shirakura K; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Kinoshita M; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Hashimoto R; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Shigesada N; Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.
  • Takahashi J; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Tachibana M; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Tanaka S; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Obana M; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Hino N; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Ikawa M; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan.
  • Tsujikawa K; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Ono C; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Matsuura Y; Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Kidoya H; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan.
  • Takakura N; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
  • Kubota Y; Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Doi T; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan.
  • Takayama K; Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
  • Yoshioka Y; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan.
  • Fujio Y; Department of Integrative Vascular Biology, Faculty of Medical Sciences, University of Fukui, Fukui 910-1193, Japan.
  • Okada Y; Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Proc Natl Acad Sci U S A ; 120(3): e2213317120, 2023 01 17.
Article en En | MEDLINE | ID: mdl-36634143
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Endotoxemia / COVID-19 Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Endotoxemia / COVID-19 Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos